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Abstract 1 
Memory loss is one of the first symptoms of typical Alzheimer’s disease (AD), for which there are 2 
no effective therapies available. The precuneus (PC) has been recently emphasized as a key area for 3 
the memory impairment observed in early AD, likely due to disconnection mechanisms within 4 
large-scale networks. Using a multimodal approach we investigated in a two-week, randomized, 5 
sham-controlled, double-blinded trial the effects of high-frequency repetitive transcranial magnetic 6 
stimulation (rTMS) of the PC on cognition, as measured by the Alzheimer Disease Cooperative 7 
Study Preclinical Alzheimer Cognitive Composite in 14 patients with early AD (7 females). TMS 8 
combined with electroencephalography (TMS-EEG) was used to detect changes in brain 9 
connectivity. We found that rTMS of the PC induced a selective improvement in episodic memory, 10 
but not in other cognitive domains. Analysis of TMS-EEG signal revealed an increase of neural 11 
activity in patients’ PC, an enhancement of brain oscillations in the beta band and a modification of 12 
functional connections between the PC and medial frontal areas.  13 
Our findings show that high-frequency rTMS of the PC is a promising, non-invasive treatment for 14 
memory dysfunction in patients at early stages of AD. This clinical improvement is accompanied by 15 
modulation of brain connectivity, consistently with the pathophysiological model of brain 16 
disconnection in AD. 17 
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1. Introduction 1 
Alzheimer’s disease (AD) typically presents with deficits in learning new information as well as in 2 
retrieving old memories (Bäckman et al. 2001). This loss in long-term episodic memory has been 3 
referred not only to local damage of the medial temporal lobes, but also to a dysfunction of large-4 
scale networks underlying memory processes. Since the early stages of AD, prominent 5 
neuropathological abnormalities (i.e., β-amyloid plaques and neurofibrillary tangles) are known to 6 
affect the posterior cortical regions of the brain, including the precuneus (PC), the posterior 7 
cingulate, the retrosplenial, and lateral posterior parietal cortex (PPC) (Buckner et al. 2005). These 8 
abnormalities are paralleled by an initial disruption of medial fronto-parietal functional 9 
connectivity, as revealed by alterations of the so-called default mode network (DMN), for which the 10 
PC is a key node (Buckner et al. 2008; Raichle et al. 2001). The disconnection of the PC precedes 11 
(and probably contributes to) the occurrence of regional brain atrophy, which becomes prominent at 12 
later disease stages (Gili et al. 2011). Indeed, AD patients often show a reduction of PC cortical 13 
thickness accompanied by an abnormal activity during memory task performance, and a decrease in 14 
functional connectivity (Chen et al. 2017). This is relevant since the activity of the PC is considered 15 
necessary for episodic memory retrieval (Lundstrom et al. 2005; Wagner et al. 2005). Therefore, the 16 
PC is a vulnerable region for the transitional stage towards dementia, and might represent an ideal 17 
target for tailored interventions aimed at counteracting AD-related memory decline. 18 
So far, the only approved treatment for AD is based on cholinergic and glutamatergic drugs. 19 
Yet, these drugs have negligible efficacy on memory deficits, and alternative strategies are needed 20 
to improve memory in patients with AD (Canter et al. 2016). Recently, non-invasive brain 21 
stimulation methods have been proposed as a novel approach to improve some cognitive 22 
performances in patients with dementia (Cotelli et al., 2006; 2008; Ferrucci et al., 2008; Turriziani 23 
et al., 2012) and in healthy volunteers (Casula et al., 2017a; Rastogi et al., 2017). These studies 24 
provided evidence that repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral 25 
prefrontal cortex (DLPFC) may transiently improve language functions, such as naming and 26 
 6 
sentence comprehension (Cotelli et al., 2011). More recently, other studies applied rTMS over 1 
different brain areas involved in the cognitive decline of AD patients (i.e. right and left DLPFC, 2 
right and left posterior parietal cortex (PPC) associative areas, and Broca and Wernicke language 3 
areas) in combination with adapted cognitive training (Bentwich et al., 2011). These studies showed 4 
promising results in terms of global cognitive functions as indexed by the improvement of the 5 
ADAS-Cog score after 5 weeks of treatment (Nguyen et al., 2017; Rabey et al., 2013). However, 6 
this approach did not show any specific effect on memory functions.  7 
Here we tested the hypothesis that rTMS of the precuneus (PC) may be a novel target to 8 
treat memory dysfunction in AD patients. This finds support in recent evidence showing that rTMS 9 
applied to key nodes of the DMN such as the PPC (Wang et al. 2014; Nilakantan et al. 2017) and 10 
PC (Rose et al. 2016; Bonnì et al. 2015) improves short and long-term memory functions in healthy 11 
individuals. Moreover, we recently demonstrated that rTMS of the PC exerts its effects not only at 12 
local but also at a network level by modulating the activity of the PC and its connections to other 13 
brain areas (Mancini et al., 2017). Therefore, we hypothesized that high-frequency excitatory rTMS 14 
of the PC might improve long-term memory in patients with AD, by modulating the neural activity 15 
of the PC and its connections with medial parietal and frontal areas. To evaluate the 16 
neurophysiological modifications induced by rTMS and potentially underpinning behavioral 17 
changes, we used single-pulse TMS combined with EEG recordings.  18 
 7 
2. Materials and Methods 1 
2.1 Experimental Design and participants 2 
The current study was approved by the Ethical Committee of Santa Lucia Foundation (Protocol 3 
number: CE/PROG.465). Written informed consent was obtained from all patients before entering 4 
the study. Neuronavigated rTMS was used to stimulate the PC of AD patients for two weeks in a 5 
sham-controlled crossover design. Thirty patients, admitted to the Specialist Memory Clinics of 6 
“Tor Vergata” University (Rome, Italy) and Catholic University of Rome (Rome, Italy) between 7 
January 2014 and June 2016 for complaining of memory symptoms, were screened for the current 8 
study. Patients’ recruitment was performed according to current diagnostic criteria for prodromal 9 
AD (Dubois et al. 2016), referring to the early symptomatic phase of AD, characterized by episodic 10 
memory loss in the presence of AD pathology as supported by CSF or imaging biomarker evidence. 11 
All AD patients had to be cognitively intact before the occurrence of cognitive impairment. 12 
Subjective memory impairment, corroborated by an informed caregiver had to occur at least 12 13 
months earlier. After the first visit, patients underwent, for diagnostic purposes, a complete clinical 14 
investigation, including medical history and neurological examination, a complete blood screening, 15 
a neuropsychiatric evaluation, brain MRI scanning, and an extensive neuropsychological 16 
assessment exploring all cognitive domains (Table 1). Lumbar puncture was performed in all 17 
patients to confirm the typical CSF profile of AD pathology, i.e., reduced concentrations of amyloid 18 
β1-42, increased levels of total- and phosphorylated-tau. Major systemic and psychiatric disorders, 19 
other neurological conditions, and signs of concomitant cerebrovascular disease on MRI scans were 20 
carefully investigated and excluded in all patients. Patients who agreed to participate (N=14; see 21 
Table 2) were randomly assigned to rTMS or sham as their first experimental arm belonging. The 22 
order of administration of either intervention (i.e., rTMS or sham) was counterbalanced across all 23 
patients. rTMS (or sham) was applied daily, at the same day-time, in a 10 session course, Monday 24 
to Friday. A two-week washout interval was applied before patients were crossed over to either 25 
experimental arm for two more weeks. Neuropsychological and neurophysiological evaluations, the 26 
 8 
latter performed by combining TMS and EEG, were performed on the Monday morning before and 1 
after each of the two week-treatment (rTMS or sham). All researchers performing patients’ 2 
evaluations were blind to their experimental arm belonging. Details of the study design are 3 
summarized in Figure 1A. 4 
 5 
2.2 Intervention - Repetitive TMS 6 
rTMS was carried out using a Magstim Rapid2 magnetic biphasic stimulator connected with a 7 
figure-of-eight coil with a 70-mm diameter (Magstim Company, Whitland, UK) that generates 2.2 T 8 
as maximum output. Each daily stimulation session consisted of 42-sec trains delivered at 20 Hz 9 
spaced-out by 28 seconds of no stimulation (total number of stimuli: 1600). The entire session 10 
lasted approximately 20 minutes. Intensity of stimulation was set at 100% of the resting motor 11 
threshold (RMT), defined as the lowest intensity producing MEPs of >50 μV in at least five out of 12 
10 trials in the relaxed first dorsal intereosseous (FDI) muscle of the right hand (Rossini et al. 13 
2015). RMT was assessed over the optimal stimulus site to elicit MEPs in the right FDI, termed 14 
“motor hotspot”, identified by positioning the coil approximately over the central sulcus and 15 
moving it on the scalp by 0.5 cm steps on left M1.  16 
During the rTMS treatment, the coil was positioned over the PC and constantly monitored 17 
using the Softaxic neuronavigation system (EMS, Bologna, Italy) coupled with a Polaris Vicra 18 
infrared camera (NDI, Waterloo, Canada). Individual T1-weighted MRI volumes were used as 19 
anatomical reference (Figure 1B). Since the coil-to-cortex distance directly affects the magnitude of 20 
magnetic stimulation, for each patient we calculated a distance-adjusted MT (AdjMT). 21 
AdjMT=MT+m×(DsiteX−DM1), where AdjMT is the adjusted MT in % of stimulator output, MT is 22 
the unadjusted MT in % of stimulator output, DM1 is the distance between the scalp and M1 23 
hotspot, DSiteX is the distance between the scalp and a second cortical region (SiteX), and m is the 24 
distance-effect gradient. This procedure provides a more accurate index of cortical excitability and 25 
improves the efficacy of MT-calibrated TMS (Stokes et al. 2005). Coil orientation was parallel to 26 
 9 
the midline with the handle pointing downward. For sham treatment, stimulation was applied using 1 
the same parameters with the sham coil positioned to the scalp in correspondence to the target area. 2 
For each patient, a source estimation on pre-processed TMS-EEG data was run at the beginning of 3 
each treatment session to confirm the correct anatomical targeting for rTMS. 4 
 5 
2.3 Cognitive Evaluations 6 
To evaluate the behavioural effects of the rTMS, we employed a battery of tests assessing long-term 7 
episodic memory, executive functions, attention, and global cognition, according to the Alzheimer 8 
Disease Cooperative Study Preclinical Alzheimer Cognitive Composite (ADCS-PACC) (Donohue 9 
et al. 2014). This battery is a well-known clinical instrument with high sensitivity to cognitive 10 
decline in prodromal and mild dementia, and with a sufficient range to detect early decline in 11 
preclinical disease stages. The battery includes: 1) the immediate and delayed total recall score from 12 
the Rey Auditory Verbal Learning test (RAVLT), to evaluate long-term episodic memory; 2) the 13 
Digit Symbol Substitution Test (DSST) from the Wechsler Adult Intelligence Scale–Revised, to 14 
evaluate response speed, sustained attention, visual-spatial skills, and set-shifting; 3) the Mini 15 
Mental State Examination (MMSE), to evaluate global cognition, and 4) the Frontal Assessment 16 
Battery (FAB), to evaluate executive functions. 17 
 18 
2.4 EEG recordings 19 
EEG was performed using a TMS-compatible EEG equipment (BrainAmp 32MRplus, 20 
BrainProducts GmbH, Munich, Germany), and was continuously recorded from 29 scalp sites 21 
positioned according to the 10-20 International System. TMS-compatible Ag/AgCl pellet electrodes 22 
were mounted on an elastic cap, while additional electrodes were used as ground and reference. 23 
Horizontal and vertical eye movements were detected by recording the electrooculogram (EOG) to 24 
off-line reject trials showing ocular artifacts. The ground electrode was positioned in AFz, while the 25 
reference one was positioned on the nose tip. The EEG and EOG signals were band-pass filtered at 26 
 10 
0.1-1000 Hz and digitized at a sampling rate of 5 kHz. Skin/electrode impedance was maintained 1 
below 5 kΩ.  2 
 3 
Resting EEG 4 
Resting EEG was recorded before each TMS/EEG session for 3 minutes with open eyes. As a first 5 
step, data were downsampled to 1000 Hz and band-pass filtered between 1 and 80 Hz (Butterworth 6 
zero phase filters). A 50 Hz notch filter was also applied to reduce noise from electrical sources. 7 
Identification and removal of artifacts (muscle activity, eye movements and blink-related activity) 8 
was made with independent component analysis (INFOMAX-ICA). Then, signal was segmented in 9 
2-sec epochs. Power density was estimated by means of the Fast Fourier Transform (10% Hanning-10 
window) from 4 to 45 Hz, with a frequency resolution of 0.5 Hz. For each participant, frequency 11 
bands were established based on two subjective anchor frequencies, which is the theta/alpha 12 
transition frequency (TF) and the individual alpha frequency (IAF) peak (Klimesch, 1997). The TF 13 
represents the minimum power in the alpha frequency range, whereas the IAF represents the 14 
frequency with the maximum power peak within the alpha range (7-12 Hz). Based on TF and IAF, 15 
we estimated the frequency band range for each participant, as follows: delta, from TF-4 to TF-2; 16 
theta, from TF-2 to TF; low alpha, from TF to IAF; high alpha, from IAF to IAF+2. For the 17 
estimation of individual beta and gamma frequencies we detected three peaks in the frequency 18 
range from IAF+2 to 45 Hz, these peaks were named beta1, beta2 and gamma peak. Low beta range 19 
was computed from IAF+2 to the lower spectral power between beta1 and beta2 peak; high beta 20 
range was computed from beta 1 to the lower spectra value power between beta 2 and gamma peak; 21 
gamma range was computed from beta 2 to 45 Hz. The mean band power was then obtained by 22 
averaging the power values of all the single-trial epochs for each participant.  23 
 24 
TMS/EEG 25 
 11 
To evaluate the neurophysiological modifications induced by rTMS and potentially underpinning 1 
behavioral changes, we used single-pulse TMS combined with EEG recordings. During all 2 
neurophysiological evaluations, patients were seated on a dedicated, comfortable armchair in a 3 
soundproof room. Each neurophysiological assessment began with a TMS-EEG session to evaluate 4 
the cortical excitability and the oscillatory activity evoked by single-pulse TMS. Single-pulse TMS 5 
was carried out using a Magstim Rapid2 magnetic biphasic stimulator connected with a figure-of-6 
eight coil with a 50-mm diameter (Magstim Company, Whitland, UK). Each TMS-EEG session 7 
consisted of 80 single pulses applied at a random inter-stimulus interval (ISI) of 2-4sec. TMS-EEG 8 
was applied over the PC, which was the target of the rTMS intervention, and over the left posterior 9 
parietal cortex (l-PPC). Importantly, we chose to stimulate the l-PPC as a control site for its 10 
proximity to the PC, since we want to assess the spatial specificity of our rTMS intervention. The 11 
order of stimulation of either area was counterbalanced across patients. The intensity of stimulation 12 
of single-pulse TMS was set at 90% of the AdjMT (PC: 57.8±3.1; l-PPC: 54.2±2.6). A short break 13 
was run between TMS-EEG stimulation of either site. The coil was differently oriented respect to 14 
the mid-sagittal axis of the patient’s head, for each stimulation site: parallel over the PC, at 15° over 15 
l-PPC, with the handle pointing backward. The coil position was constantly monitored using the 16 
Softaxic neuronavigation system, to ensure a high degree of reproducibility across 17 
neurophysiological assessments.  18 
TMS-EEG data were preprocessed offline using Brain Vision Analyzer (Brain Products 19 
GmbH, Munich, Germany). TMS-EEG data were analyzed offline with Brain Vision Analyzer 20 
(Brain Products GmbH, Munich, Germany) and EEGLAB toolbox running in a MATLAB 21 
environment (MathWorks Inc., Natick, USA; Delorme and Makeig, 2004). As a first step, a cubic 22 
interpolation from 1 ms before to 10 ms after the TMS pulse was applied to remove the TMS 23 
artifact. Afterwards, the signal was downsampled and filtered as on the resting EEG data. 24 
Physiological and TMS-related artefactual components were detected using INFOMAX-ICA and 25 
removed basing on their scalp distribution, frequency, timing and amplitude (Casula et al., 2017b). 26 
 12 
Data were then segmented into epochs starting 1 s before the TMS pulse and ending 1 s after it. 1 
Afterwards, all the epochs were visually inspected and those with excessively noisy EEG were 2 
excluded from the analysis, resulting 68.7±2.9 in the pre-rTMS condition, 68.9±2.9 in the post-3 
rTMS, 70.7±2 in the pre-sham, 70.1±2.1 in the post-sham, stimulating the PC. For l-PPC 4 
stimulation, we used 76.5±1.1 trials in the pre-real condition, 76.1±1.9 in the post-real, 76.4±0.8 in 5 
the pre-sham, 76.9±1.4 in the post-sham. 6 
Two sets of outcome measures were obtained, assessing, respectively, cortical excitability 7 
(using a spatio/temporal-domain analysis) and cortical oscillatory activity (using a time/frequency-8 
domain analysis). To evaluate changes in cortical excitability, we evaluated both, global and local 9 
cortical responses evoked by TMS. The global response was assessed, for each patient and each 10 
stimulation site (PC and l-PPC), by measuring the first five peaks (10-35 ms for P1; 36-62 ms for 11 
P2; 63-90 ms for P3; 91-165 ms for P4 and 166-250 ms for P5) of the global mean field power 12 
(GMFP) waveform within the 300 msec following the TMS pulse. Local responses were measured 13 
by the TMS-evoked potentials (TEPs) waveform at each electrode within the five temporal 14 
windows used for GMFP analysis.  15 
To evaluate changes in the oscillatory domain, we performed a time/frequency 16 
decomposition based on Morlet wavelet (parameters c=3; 41 linear 1 Hz steps from 4 to 45 Hz), and 17 
then we computed event-related spectral perturbation (ERSP) and inter-trial coherence (ITC). ERSP 18 
is a measure of event-related changes in spectral power over time in a certain frequency range 19 
computed as: 20 
𝑇𝑇𝑇𝑇(𝑓, 𝑡) = 1
𝑛
�|𝐹𝑘(𝑓, 𝑡)|2𝑛
𝑘=1
 
Where, for n trials, the spectral estimate F was computed at trial k, at frequency f and time t. 21 
ITC is a measure of the partial or exact synchronization of activity at a particular latency and 22 
frequency to an experimental event to which EEG data trials are time locked (i.e. TMS pulse), 23 
computed as: 24 
 13 
𝐼𝑇𝐼(𝑓, 𝑡) = 1
𝑛
�
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ITC coefficient takes value between 0 and 1, where 0 represents absence of synchronization 1 
between EEG data and the time-locked event and 1 represents their perfect synchronization. 2 
Analysis of ERSP values was conducted over five regions of interest (ROI), each one comprising 3 
three electrodes: frontal ROI (F3, Fz, F4); central ROI (C3, Cz, C4); parietal ROI (P3, Pz, P4); left 4 
ROI (F7, T7, P7) and right ROI (F8, T8, P8). To minimize the effect of possible artifacts occurring 5 
at the time of stimulation, the frequency values were averaged over a 20-250 ms time window from 6 
the TMS pulse, corresponding to the timing of the oscillatory activity. The spectral power was 7 
computed in the frequency ranges between 4-7 Hz (theta), 8-13 Hz (alpha), 14-30 Hz (beta) and 31-8 
45 Hz (gamma). 9 
 10 
2.5 Statistical Analysis 11 
To assess the effect of rTMS on patients’ performance at RAVLT, repeated-measures ANOVAs 12 
with treatment (rTMS or sham) and time (pre- or post-treatment) as factors were performed. The 13 
same test was used to assess changes in the patients’ performance at all tests included in the ADCS-14 
PACC, to ensure that the improvement induced by rTMS was specific for episodic memory. 15 
To assess the rTMS effect on the spectral power of resting EEG we used a repeated-16 
measures ANOVAs with factors treatment (rTMS and sham) and time (pre- and post-treatment) 17 
separately conducted for each frequency band (delta, theta, low alfa, high alfa, low beta, high beta 18 
and gamma). Effects on amplitude of GMFP peaks (global response) were measured with a 19 
repeated-measures ANOVA with factors treatment (rTMS and sham), time (pre- and post-20 
treatment) and peak (P1, P2, P3, P4, P5) performed separately for the two stimulation sites (PC or l-21 
PPC).  22 
To assess the treatment effects on local cortical response over the PC and the l-PPC, we used 23 
multiple dependent t-tests comparing TEPs waveform at each electrode within the five temporal 24 
 14 
windows used for GMFP analysis. Non-parametric, cluster-based permutation statistics was 1 
conducted to correct for multiple comparisons (Maris et al. 2007). This method performs a non-2 
parametric statistical test by calculating Monte Carlo estimate of the significance probabilities from 3 
two surrogate distributions constructed by randomly permuting the two original conditions data for 4 
3000 times (Casula et al., 2017c). The clusters for permutation analysis were defined as the two (or 5 
more) neighboring electrodes in which the t-value at a given time point exceeded a threshold of 6 
P<0.05.  7 
Repeated-measures ANOVA with factors region-of-interest (frontal, central, parietal, left, 8 
right), treatment (rTMS or sham) and time (pre- or post-treatment) were performed to evaluate the 9 
rTMS effects on oscillatory activity (ERSP), separately for each frequency band. Analysis of ITC 10 
was conducted on the beta-band activity (14-30 Hz) considering the electrode over the stimulation 11 
site, i.e., Pz for the PC and P3 for l-PPC. Repeated-measures ANOVA with treatment (rTMS or 12 
sham) and time (pre- or post-treatment) as factors was performed to evaluate the effects of rTMS on 13 
ITC beta-band activity.  14 
For all the ANOVA procedures, the Huynh–Feldt ε correction factor was applied where 15 
appropriate to compensate for effects of non-sphericity. Bonferroni’s correction was applied to 16 
post-hoc comparisons.  17 
 18 
2.6 Source analysis 19 
In order to confirm the targeting of the stimulation, as a preliminary analysis, we used source 20 
estimation on the pre-processed TMS-EEG data at the beginning of the treatment for each subject. 21 
Briefly, using BrainStorm software we estimated the activity of the dipoles underlying the brain 22 
electrical activity, by means of the ICBM152 template (Tadel et al., 2011). Since this kind of 23 
inverse problem presents an infinite number of dipole patterns that could generate the same 24 
electrical activity registered by the electrodes, we used minimum norm imaging to approach the 25 
forward modelling. As a preliminary step, this method finds a cortical current source density 26 
 15 
distribution that can approximate the data, and then defines the solution with the minimum energy, 1 
using source covariance. We modelled one dipole at each grid point, normally oriented to the 2 
cortical surface. We then used the standardized low-resolution brain electromagnetic tomography 3 
(sLORETA) measure to normalize the current density map at each point (Pascual-Marqui et al., 4 
2002). The estimated source distribution was averaged across the patients (Supplementary Movie 1) 5 
and the PC was selected as region of interest using the definition of the Desikan-Killiany atlas 6 
(Desikan et al., 2006). 7 
 8 
2.7 Behavioral-neurophysiological correlations 9 
In order to investigate possible relationships between clinical and neurophysiological outcomes, we 10 
tested correlations using the Pearson's coefficient (two-tailed) between the modulations observed in 11 
the RAVLT and in the GMFP.  12 
 16 
3. Results 1 
Fourteen patients with AD (F/M=7/7) took part in the study, which was conducted between January 2 
2014 and June 2016. Demographic and clinical characteristics of the cohort are summarized in 3 
Table 1. They all completed the protocol successfully, attending all experimental sessions.  4 
 5 
3.1 Source analysis 6 
The source analysis of TMS-evoked EEG activity showed that the response was spatially 7 
distributed along the wall of the medial superior parietal cortex bilaterally, corresponding to the PC 8 
(Movie 1) (Bzdok et al. 2015). This confirmed, in all participants, a correct anatomical 9 
identification of the stimulation site (Figure 1C). The Montreal Neurological Institute (MNI) 10 
coordinates of the stimulation site averaged across participants were [x,y,z]=[0,-65±2,37±9]. The 11 
mean scalp-to-cortex distance for the PC was 27±0.3 mm, and the AdjMT for rTMS was 60.8±3.1% 12 
of maximum stimulator output. 13 
 14 
3.2 Cognitive evaluation 15 
ANOVA on the performance at Delayed Recall of the Rey Auditory Verbal learning Test showed a 16 
significant time × treatment interaction [F(1.13)=5.98; p=0.029] (Figure 2). Post-hoc analysis 17 
revealed a significant improvement at the test performance after rTMS (pre vs. post, 2.42±0.8 vs. 18 
3.14±0.8). No significant effects were detected after sham stimulation (post vs. pre, 2.86±0.7 19 
vs.2.50±0.8). No significant effects were observed on patients’ executive functions, attention or 20 
global cognition (all ps>0.05, table 3). 21 
 22 
3.3 Resting EEG 23 
ANOVAs performed on the mean spectral power for each frequency band, did not reveal any 24 
significant main effect of rTMS (all ps>0.05), time (all ps>0.05), nor any significant interaction 25 
between the two factors (all ps>0.05). 26 
Comment [Cla1]: Credo sia SEM 
Comment [Cla2]: SEM 
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 17 
 1 
3.4 TMS-evoked cortical activity 2 
ANOVA performed on mean TMS-evoked activity evaluated over PC revealed a significant rTMS 3 
× time × peak interaction [F(4.52)=5.74; p =0.0006], due to a significant increase of P3 after real 4 
rTMS treatment (Figure 3a). Post-hoc analysis showed for P3 a significant difference between pre 5 
and post real rTMS treatment (p=0.008), and between post real and post sham (p=0.005). For all 6 
peaks, no significant differences were observed between baseline of each rTMS treatment (all 7 
ps>0.05) and between pre and post sham rTMS (p>0.05, Ffigure 3b). No significant effects were 8 
found when stimulating l-PPC indicating that the rTMS protocols was unable to induce a general 9 
effects on cortical excitability of surrounding cortical sites (Ffigure 3c,d). When stimulating the PC, 10 
the cluster-based analysis did not reveal any significant difference between the baselines of the two 11 
groups (i.e. pre-sham rTMS vs. pre-real TMS; Monte Carlo p>0.05). As revealed by TEPs and 12 
GMFP amplitude, PC-rTMS produced a significant increase of TMS-evoked activity from PC over 13 
a specific time window, i.e. from 60 to 90 ms after TMS over two distinct cluster of electrodes: one 14 
frontal, comprising Fz, FC2 and F4 electrodes; and one parieto-occipital, comprising Pz, O1 and O2 15 
(Monte-Carlo p<0.01). No difference was detected after sham stimulation, nor after stimulation of l-16 
PPC (Monte-Carlo p>0.05).  17 
 18 
3.5 TMS-evoked oscillatory activity 19 
ANOVA performed on mean ERSP values evaluated over PC revealed a significant ROI × rTMS × 20 
time interaction when beta oscillatory activity was evaluated [F(4.52)=3.093; p=0.023]. Post-hoc 21 
analysis showed a significant increase of beta activity over the parietal ROI in the post- rTMS 22 
condition compared to pre- (3.565±0.37 vs. 2.257±0.46 μV; p=0.021) (Figure 4a). No effect was 23 
revealed in the sham rTMS condition (Figure 4b), nor between the baselines of the two conditions 24 
(pre-real rTMS vs. pre-sham rTMS; p>0.05). ANOVA did not reveal any significant differences in 25 
the other frequency bands (all ps>0.05). 26 
 18 
ANOVA performed on mean ITC values evaluated over PC revealed a significant rTMS × time 1 
interaction when beta oscillatory activity was evaluated [F(1.13)=11.36; p=0.005]. Post-hoc 2 
analysis showed a significant increase of beta activity after rTMS condition compared to pre- 3 
(0.0006±0.01 vs. 0.007±0.01; p=0.002) (Figure 4c). Again, no significant effects were observed 4 
after sham treatment (Figure 4d) nor when stimulating the l-PPC (Figure 4e-h). 5 
 6 
3.6 Behavioral-neurophysiological correlations 7 
Analysis of relationships between clinical and neurophysiological data did not reveal any significant 8 
correlation (all ps>0.05).  9 
 19 
4. Discussion 1 
We evaluated here the usefulness of rTMS in modifying selectively the cognitive performance of 2 
patients with typical AD at early clinical stages. In our patient sample, we demonstrated a 3 
significant beneficial effect of this intervention in improving episodic memory. Our 4 
neurophysiological data suggest that this improvement is underpinned by changes in cortical 5 
activity of the PC and its connectivity with frontal areas. 6 
rTMS induced an average increase of 0.8 recalled items (36%) at RAVLT (delayed recall). 7 
These results provide the first evidence that rTMS could be used as a non-pharmacological 8 
intervention to counteract memory loss in AD. The study design was rigorous, with rTMS being 9 
sham-controlled in a cross-over design. AD patients, as well as experimenters performing 10 
evaluations were blind to the treatment condition at any time of the study – thus minimizing the risk 11 
of observing a placebo effect. Despite the sample was relatively small, these results are robust, and 12 
could provide the basis for planning a clinical trial with a between-group design aimed at evaluating 13 
the potential beneficial effects of rTMS of the PC in slowing cognitive decline when applied during 14 
a longer period (i.e. six months). 15 
In all AD patients, rTMS delivery on the PC was strictly verified in terms of anatomical 16 
localization by a source reconstruction analysis of TMS-evoked EEG activity, using a 17 
neuronavigation system. Critically, cognitive evaluations were constantly paralleled by TMS-EEG 18 
monitoring, thus allowing a concomitant assessment of the clinical effect of rTMS alongside with 19 
information on neurophysiological modulation of the brain. Taken altogether, these findings 20 
provide novel evidence that non-invasive treatment of network dysfunction, through stimulation of 21 
the PC, represents an effective strategy to enhance long-term memory in AD. 22 
The rTMS-induced improvement of long-term memory reinforces the notion that PC is 23 
directly involved in memory dysfunction in prodromal AD (Lundstrom et al. 2005). With this 24 
regard, recent models of long-term memory showed that, in healthy conditions, the encoding of 25 
episodic memory is associated with reduced PC activity, while the retrieval is associated with 26 
 20 
increased PC activity (Daselaar et al. 2009). This interaction, which has been termed “the 1 
encoding/retrieval flip” (Huijibers et al. 2012), is reduced in elderly adults with amyloid pathology 2 
(Vannini et al. 2012). Moreover, memory recall is associated with greater activity in medial regions 3 
of the DMN in both, healthy subjects and AD patients (Dhanjal et al. 2014). It is therefore plausible 4 
that the excitatory rTMS protocol we applied here could have reinforced this memory-related 5 
cortical mechanism by increasing PC activity.  6 
From a neurobiological perspective, rTMS could have induced clinical improvement by 7 
promoting changes in synaptic plasticity, the most important biological mechanism for learning and 8 
memory. Long-term potentiation (LTP) is considered as a main neurophysiological correlate of 9 
these cognitive functions (Bliss and Lømo 1973). We recently demonstrated that AD patients show 10 
a disruption in LTP-like cortical plasticity since early clinical stages (Koch et al. 2012; Di Lorenzo 11 
et al. 2016). In this context, high-frequency rTMS might have induced LTP-like cortical plasticity 12 
within the PC of our cohort of AD patients. Consistent with this hypothesis, TMS-EEG analysis 13 
revealed a specific increase of PC neural activity. This enhancement was evident not only at a local 14 
but also at a network level. Indeed, changes in neural activity were located over two distinct clusters 15 
of electrodes: one corresponding to the site of stimulation (PC), one corresponding to the medial 16 
frontal cortex, suggesting that rTMS induced relevant modulations over a medial parieto-frontal 17 
circuit. Interestingly, the topography of this EEG network resembles the anatomical distribution of 18 
the DMN, as identified by functional MRI (Buckner et al. 2008; Raichle et al. 2001). We also found 19 
that rTMS induced an enhancement of TMS-evoked beta activity, both in terms of power and phase 20 
synchronization, focused over the medial parietal electrodes underlying the site of rTMS delivery. 21 
Since we applied rTMS at 20 Hz, a frequency that falls within the range of beta oscillations, our 22 
results could be explained by a possible long-lasting entrainment of beta-rhythm induced by rTMS 23 
(Rosanova et al. 2009). In this perspective, our findings are in agreement with models proposing 24 
beta activity as an efficient cortical frequency through which the brain networks communicate 25 
relevant information, playing a pivotal role on different memory processes (Feurra et al. 2016).  26 
 21 
The main limitation of this study is the relatively small sample size. However, in order to 1 
select a homogeneous cohort, the clinical diagnosis of AD was supported by the use of CSF 2 
biomarkers in all participants, according to the current diagnostic criteria (Dubois et al. 2016). In 3 
addition, the low number of electrodes used for EEG recordings limits the spatial resolution of our 4 
conclusions, especially for the source analysis. In spite of these limitations, to our knowledge, this 5 
is the first study that investigated both the behavioral and neurophysiological effects of an rTMS 6 
protocol in AD patients. From a methodological point of view, we demonstrated the reliability of 7 
the TMS-EEG approach in revealing specific cortical changes that were not detectable by the 8 
resting EEG analysis. 9 
In conclusion, our results show novel evidence that rTMS may be a potential effective 10 
strategy for treating patients with early AD for whom, currently, there is no available therapy. Our 11 
work is in line with an emerging framework considering circuit-based dysfunctions as a model for 12 
cognitive impairment (Canter et al. 2016), and identifies the PC as a novel interventional target to 13 
successfully improve memory in AD.  14 
  15 
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Table 1. Neuropsychological assessment at baseline of AD patients. 1 
Cognitive Domain Neuropsychological test  score 
LONG TERM MEMORY   
Verbal memory Free and cued selective reminding test  
 Immediate Free Recall (cut-0ff ≥19.59) 17.0 (1.3) 
 Immediate Total Recall (cut-off ≥35) 26 (3) 
 Delayed Free Recall (cut-off ≥6.31) 4.0 (1.2) 
 Delayed Total recall (cut-off ≥11) 8 (1.7) 
 Short story test  
 Immediate Recall 
(cut-off ≥3.1) 
3.9 (2.7) 
 Delayed recall 
 (cut-off ≥2.6) 
3.6 (2.3) 
Visuo spatial memory Rey’s Complex figure  
 Immediate recall (cut-off ≥6,4) 11.2 (8.1) 
 Delayed recall 
(cut-off ≥6.3) 
7.9 (4.7) 
SHORT TERM MEMORY   
Verbal 
 
Digit span (≥3.7) 4.8 (1.3) 
Spatial Corsi block tapping task (3.5) 4.1(0.6) 
LANGUAGE Naming of object from BADA (≥22) 28.0(3.5) 
REASONING Raven’s Progressive Matrices (≥18.9) 26.2 (6.3) 
EXECUTIVE Modified Card Sorting test  4.4 (0.7) 
 31 
 1 
The table shows the mean (SD) performance scores obtained on neuropsychological testing. For 2 
each administered test appropriate adjustments for gender, age and education were applied 3 
according to the Italian normative data. Available cut-off scores of normality ( ≥ 95% of the lower 4 
tolerance limit of the normal population distribution) are also reported for each test. 5 
  6 
FUNCTIONS criteria achived (cut-off≥4.2) 
 Modified Card Sorting test perseverative 
errors (cut-off≥7.6) 
6.0 (2.0) 
 Phonological verbal fluency(≥17.3) 33.8 (7.3) 
PRAXIS ABILITIES Copy of drawing (cut-off ≥7.1) 9.5 (1.3) 
 Copy of drawing with landmarks 
cut-off ≥61.8 
67.0 (1.8) 
ATTENTION Trail Making Test A (≤94 sec) 76 (13) 
 Trail Making Test B (≤283 sec)  136 (21) 
 Trail Making Test A-B (≤187 sec) 85 (17) 
 32 
Table 2. Principal Demographic and Clinical Characteristics of AD patients. 1 
 
 
 
 
AGE, years (mean ±SD) 70.0 ± 5.1 
SEX ,% female 50 
EDUCATION, years (mean ±SD) 7.2 ± 3.0 
MMSE (mean ±SD) 26.1 ± 1.8 
ADL (mean ±SD) 5.6 ± 0.5 
IADL (mean ±SD) 7.3 ± 0.6 
CDR (mean ±SD) 0.3 ± 0.3 
Disease duration (months) 13.8 ± 5.1 
CSF beta 1-42 pg/mL (mean ±SD) 383.1 ± 16.2 
CSF total tau pg/mL(mean ±SD) 558.3 ± 190.7 
CSF p-tau pg/mL(mean ±SD) 72.8± 16.2 
APOE ε4+ % 65 
 2 
Abbreviations: AD=AD; MMSE: Mini-Mental State Examination; ADL: Activities of daily Living; 3 
IADL: Instrumental activities of Daily living; CSF: cerebrospinal fluid; SD: Standard deviation. 4 
 5 
  6 
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Table 3. Cognitive performances of AD patients in different experimental conditions. 1 
 2 
Abbreviations: rTMS: repetitive transcranial magnectic stimulation; MMSE: Mini-Mental State 3 
Examination; RAVLT: Rey Auditory Verbal learning Test (IR: Immediate Recall; DR: Delayed 4 
Recall); DSST: Digit Symbol Substitution Test.  5 
Cognitive test pre rTMS post rTMS pre sham post sham 
ANOVA 
Group x time 
MMSE 26.9± 1.9 27.3± 1.6 25.8± 2.1 26.7± 2.6 p=n.s. 
RAVLT (IR) 25.4 ±6.5 26.4 ±7.7 25±8.0 25.9 ±8.2 p=n.s. 
RAVLT (DR) 2.2 ± 2.7 3.0 ± 2.6 2.4 ±2.7 2.4 ±2.9 p=0.02* 
FAB 14.1 ± 2.2 13.9±1.9 14.0±2.2 14.3±2.5 p=n.s. 
DSST 89.4± 2.7 90.3± 1.7 89.3± 2.5 89.2± 2.7 p=n.s. 
 34 
Figure legends 1 
Figure 1. Experimental design and source analysis reconstruction.  2 
(A) AD patients (n=14) were randomly assigned to either a first neuronavigated rTMS or control 3 
stimulation (sham) arm. rTMS/sham was daily applied in a 10-session course, Monday to Friday, 4 
for a total duration of two weeks. A two-week washout interval was then applied, following which 5 
patients were crossed over to the alternative study arm for two additional weeks. The order of 6 
assignment to either study arm was counterbalanced across patients. (B) rTMS was applied over the 7 
PC at 20 Hz (1600 stimuli per day), using a neuronavigation system to ensure that the same spot 8 
was constantly stimulated across sessions. (C) Source analysis of TMS-evoked EEG activity 9 
showed a bilateral activation of the PC, as reconstructed at the peak fit of cortical response between 10 
60 and 90 ms from PC stimulation with single-pulse TMS. 11 
 12 
Figure 2. Behavioral results.  13 
(A) Learning curves for the 15 word-list of the Rey Auditory Verbal Learning Test before and after 14 
two weeks of treatment with rTMS (left panel) or sham (right panel). (B) Immediate (IR) and (C) 15 
Delayed Recall (DR) of the Rey Auditory Verbal Learning Test before and after two weeks of 16 
treatment with rTMS or sham. * p<0.05. Error bars indicate SEM. 17 
 18 
Figure 3. TMS/EEG evoked responses in the spatio/temporal domain.  19 
(A) rTMS, but not sham (B) increases cortical activity from 60 to 90 ms (red thick line) following a 20 
single-pulse TMS applied over the PC. Such increase is spatially distributed over the electrodes 21 
located on the medial fronto-parietal areas, as shown by the scalp maps of surface voltage 22 
distribution. (C, D) No significant effects are detectable when conducting the same analysis on the 23 
cortical response after single-pulse TMS of the l-PPC. *P<0.05. Line shading indicated SEM 24 
 25 
Figure 4. TMS/EEG evoked responses in the time/frequency domain: ERSP  26 
 35 
(A) rTMS, but not sham (B), enhances PC beta activity in terms of spectral power, as revealed by 1 
event-related spectral perturbation (ERSP). No significant effects are detectable when the same 2 
analysis is conducted on the l-PPC (C,D). *P<0.05. Error bars indicated SEM. 3 
 4 
Figure 5. TMS/EEG evoked responses in the time/frequency domain: ITC  5 
(A) rTMS, but not sham (B), synchronized PC beta oscillatory activity, as revealed by inter-trial 6 
coherence (ITC). No significant effects are detectable when the same analysis is conducted on the l-7 
PPC (C,D). *P<0.05. Error bars indicated SEM. 8 
